Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Diabetes
•
Endocrinology
What is your approach to addressing severe dawn phenomenon in your patients with diabetes?
Related Questions
What is the rationale behind the Anesthesiology recommendation to hold one dose of weekly GLP-RA prior to general anesthesia?
How do you approach the use of metformin in the management of prediabetes for patients who are neither obese nor have a family history of diabetes?
What is your experience with the use of automated insulin delivery systems (such as Control IQ with Tandem insulin pumps) in pregnant patients with diabetes?
Would you consider GLP1 R agonist therapy in a patient with a history of severe gallstone pancreatitis that is now post cholecystectomy?
What work-up should be considered in patients with significantly worsening A1c despite steady diet, lifestyle, and medication adherence?
Is ABI (Ankle Brachial index) lower limb arterial doppler not recommended if patient already has arterial stents in the legs, and if so, what other imaging modality would you consider as first-line?
How do you counsel patients on semaglutide or tirzepatide in light of potential cancer risks?
What are the potential causes for significant discrepancies between predicted A1c by Dexcom CGM and standard serum A1c by lab draw?
Do you recommend neuromodulation treatments with an implantable device for patients with chronic painful diabetic neuropathy who have not responded to common oral therapies such as Gabapentin and Amitriptyline?
Should short courses of insulin be considered for steroid-induced hyperglycemia in patients with pre-diabetes or mild diabetes well controlled on oral therapy?
